Candidate therapy MRT-6160 chosen for MS, other autoimmune diseases | Multiple Sclerosis News Today

MRT-6160 has been selected for development by Monte Rosa Therapeutics for the treatment of multiple sclerosis and other autoimmune disorders.

Related Keywords

Markus Warmuth ,Monte Rosa ,Bowen Wallace , ,Monte Rosa Therapeutics ,